Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05615844 · ClinicalTrials.gov registry record · Phase 3

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

A Phase 3 study of Open tíbia Fracture, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
Phase 3
Development phase
312
Enrollment target
20
Study locations

NCT05615844: Recruiting Phase 3 study of Open tíbia Fracture, sponsored by University of Maryland, Baltimore.

NCT05615844 is a Phase 3 study of Open tíbia Fracture that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 312 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05615844, a Phase 3 study of Open tíbia Fracture, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
Phase 3
Development phase
312 participants
Enrollment target
20
Study locations

Study Summary

The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participants will be randomized to receive either an antibiotic bead pouch or negative pressure wound therapy (NPWT) for their temporary open fracture wound management. Outcomes will be assessed at 6 weeks, 3 months, and 6 months post-surgery. The primary outcome will be a composite outcome to evaluate clinical status six months after randomization. Components of the composite outcome will be hierarchically assessed in the following order: 1) all-cause mortality, 2) injury-related amputation of the lower extremity, 3) unplanned reoperation to manage wound complications, infection, or delayed fracture healing, and 4) clinical fracture healing as assessed using the Functional IndeX for Trauma (FIX-IT) instrument. The secondary outcomes will independently assess the four components of the primary outcome. This is a Phase III trial.

Primary Outcome

Clinical status is a hierarchal composite of the following outcomes: i) all-cause mortality ii) amputation at the fracture location iii) unplanned reoperation to manage wound complications, an infection, or promote fracture healing, iv) clinical fracture healing assessed using the Functional IndeX for Trauma (FIX-IT) instrument.

Conditions Studied

Interventions

  • DRUG Antibiotic Cement Bead Pouch
  • DEVICE Negative Pressure Wound Therapy

Study Locations (20)

California

  • University of California, Davis - Davis
  • University of Southern California - Los Angeles
  • Cedars-Sinai Medical Center - Los Angeles
  • University of California, Irvine - Orange

Florida

  • University of Florida - Gainesville
  • University of Miami - Miami

Maryland

  • University of Maryland, R Adams Cowley Shock Trauma Center - Baltimore
  • University of Maryland Capital Region Health - Largo

Ohio

  • University of Cincinnati - Cincinnati
  • Bon Secours Mercy Health - Cincinnati

Arizona

  • Dignity Health Chandler Regional Medical Center - Chandler

Connecticut

  • Yale University - New Haven

Indiana

  • Indiana University - Indianapolis

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2023-11-05
Est. Completion 2027-10-01
Phase Phase 3
University of Maryland, Baltimore

560 total trials

What NCT05615844 shows while recruiting

NCT05615844 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Open tíbia Fracture appearing as the primary indexed condition, and to 2 interventions - of which Antibiotic Cement Bead Pouch is the first listed.

NCT05615844 names 20 study sites across 14 states, led by California, Florida, Maryland.

Frequently Asked Questions

What is clinical trial NCT05615844 about?

NCT05615844 is a clinical study titled "Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy". The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participants will be randomized to receive either an antibiotic bead pouch or negative pressure wound therapy (...

What is the current status of trial NCT05615844?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2023-11-05. Estimated completion is 2027-10-01.

What conditions does trial NCT05615844 study?

This clinical trial studies the following conditions: Open tíbia Fracture.

What interventions are being tested in trial NCT05615844?

The interventions under investigation include: Antibiotic Cement Bead Pouch (DRUG), Negative Pressure Wound Therapy (DEVICE).

Who is sponsoring clinical trial NCT05615844?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05615844 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Open tíbia Fracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05615844's enrollment target sits among peer trials

312 1103rd of 2000 higher than 895 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04984551 · 312 participants · Phase 2

    Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

  • NCT04999904 · 312 participants · NA

    A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability

  • NCT05220332 · 312 participants · NA

    Church-based Intervention to Improve Blood Pressure in African Americans

  • NCT05434234 · 312 participants · Phase 1

    A Study of YL201 in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05615844, the US trial registry maintained by the National Library of Medicine. NCT05615844 (mid enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.